Lisdexamfetamine Dimesylate (LDX)
SPD489-325
Phase 3 small_molecule completed
Quick answer
Lisdexamfetamine Dimesylate (LDX) for ADHD is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 3 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- ADHD
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed